|

Palifermin Clinical Trials

1 actively recruiting trial across 1 location

No change since March 2026

Also known as: Growth Factor, Recombinant Human Keratinocyte, Kepivance, Keratinocyte Growth Factor, Recombinant Human, Recombinant Human Keratinocyte Growth Factor, rhKGF +1 more

Pipeline

Phase 2: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Refractory Myelodysplastic Chronic Myelomonocytic Leukemia1
  • Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia1
  • Myelodysplastic Chronic Myelomonocytic Leukemia1
  • Acute Myeloid Leukemia With Complex Karyotype1
  • Refractory Secondary Acute Myeloid Leukemia1

Duarte, California1 trial

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

City of Hope Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.